CAS 与 PatSnap 建立战略合作伙伴关系,整合行业领先的科学内容和 AI 驱动技术,加速全球创新
CAS 与 PatSnap 建立战略合作伙伴关系,整合行业领先的科学内容和 AI 驱动技术,加速全球创新。领先的科技信息解决方案的强强联合,将为整个研发和专利工作流程提供更深入的见解。
CAS 与 PatSnap 建立战略合作伙伴关系,整合行业领先的科学内容和 AI 驱动技术,加速全球创新。领先的科技信息解决方案的强强联合,将为整个研发和专利工作流程提供更深入的见解。
Syngenta invests in SciFinder from CAS to enhance research efficiency and bring sustainable agricultural solutions to market faster. Advanced scientific information solutions proving to be a critical driver of productivity for leading innovators as the volume of published scientific data grows.
秉承致力于帮助研发领导者加速科学发现的愿景,美国化学会(ACS)旗下分支机构美国化学文摘社(CAS)今日宣布其突破性的逆合成设计工具正式上线SciFindern。这一计算机辅助合成设计(CASD)解决方案,将CAS科学家标引的无以伦比的反应集合与AI技术相结合,并利用John Wiley and Sons,Inc.屡获殊荣的ChemPlanner技术生成已知以及新化合物的预测逆合成路线。
As part of the continued commitment to helping R&D leaders accelerate scientific discovery, CAS announced the launch of a breakthrough retrosynthetic capability in SciFinder . This computer-aided synthetic design (CASD) solution utilizes AI technology, powered by CAS’s unmatched collection of scientist-curated reaction content and leverages John Wiley and Sons, Inc.’s award-winning ChemPlanner technology to now identify predicted retrosynthetic routes for both known and novel compounds.
CAS has partnered with Scilligence to integrate SciFinder with Scilligence ELN (Electronic Laboratory Notebook). This integration helps scientists simplify their workflow by allowing easy access to vital research information in SciFinder while maintaining traceability of their ideas. Structure and reaction searches in SciFinder can now be initiated directly from Scilligence ELN.
CAS continues its partnership with iChemLabs to optimize the efficiency of chemical structure searching and drawing in SciFinder using ChemDoodle®. Advanced SciFinder searches are now immediately accessible to ChemDoodle users to increase workflow efficiency.
保诺选择CAS的SciFindern来提高研究效率并缩短达成客户要求所需周期. 制药公司与CRO合作伙伴在快速发展的商业环境中携手推动创新.
BioDuro chooses SciFinder to enhance research productivity and shorten cycle times for client success
Collaboration between drug companies and contract research partners drives innovation in evolving business environment.
CAS has expanded its product portfolio with the launch of Formulus®, a new solution aimed at getting innovations to market faster by addressing the unique information needs of formulations scientists.